1. Signaling Pathways
  2. Immunology/Inflammation
  3. ALCAM/CD166
  4. ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitor

ALCAM/CD166 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-P99788
    Praluzatamab
    Inhibitor
    Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.